MedPath

Cuff Leak Test and Airway Obstruction in Mechanically Ventilated ICU Patients

Phase 3
Completed
Conditions
Respiratory Failure
Interventions
Diagnostic Test: Cuff Leak Test
Registration Number
NCT05456542
Lead Sponsor
St. Joseph's Healthcare Hamilton
Brief Summary

The COSMIC trial will be a multicentred, national, parallel-group, pragmatic vanguard pilot trial.

Detailed Description

The COSMIC trial will be a multicentred, national, parallel-group, pragmatic vanguard pilot trial in adults (≥18 years) who are mechanically ventilated in the ICU with risk factors for LE and an order to extubate has been provided by the treating physician.

The aims of this study are to assess:

1. Protocol adherence

2. Recruitment rates

3. Secondary clinical outcomes will be collected, and if feasibility criteria are met, ultimately used in the powered trial pending no major protocol adjustments (otherwise will be reported as cohort data).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • ≥18 yrs. of age

  • Mechanically ventilated in the ICU \

  • An order to extubate has been provided by the treating physician

  • Meet at least 1 criteria for risk factors for Laryngeal Edema(LE):

  • Criteria 1

  • Intubated for >5 days

  • Criteria 2 *must fulfill category 1 and ≥1 risk factor in category 2

  • Category 1

    • Intubated for >48 hours
  • Category 2

    • An unplanned extubation event within the last week
    • Airway trauma secondary to an endotracheal intubation during the past week defined as one of the following:
    • More than one attempt at direct laryngoscopy
    • More than one attempt to pass the ETT
    • Charted as a traumatic intubation
  • A body mass index of >30kg/m2

  • An endotracheal tube greater than 8mm in a man or 7mm in a woman

  • A total positive cumulative fluid balance of at least >1500ml/d x # of days admitted to ICU (eg. If admitted for 4 days, the patient will meet this criterion if they are 6L positive during their length of ICU admission)

  • Physician concern about possible laryngeal edema for a reason not previously listed above. For example:

  • Prone or Trendelenburg position in a recent operation

  • Agitation defined as a RASS of 3+ or more or a SAS of 6 or more that may result in airway injury

Exclusion Criteria
  • Palliative care plan or plan of care does not include re-intubation, Decision to withdraw life support, or no plan for re-intubation
  • Known pregnancy: Current pregnancy or up to and including 7 days postpartum
  • Patients with highly suspected laryngeal injury: Burn patients, smoke inhalation injuries, blunt or penetrating trauma of the neck and airway, recent head and neck surgeries, and patients admitted with airway edema
  • Known pre-existing tracheolaryngeal abnormalities: Vocal cord paralysis, tracheolaryngeal neoplasm, tracheomalasia, tracheolaryngeal stenosis, or previous head and neck surgeries
  • Mechanical ventilation via a tracheostomy
  • High dose steroids administered within the previous 72h (Prednisone 1mg/kg oral equivalent)
  • The ICU physician believes the patient should have a CLT performed
  • Patient had a failed CLT in the previous 24 hours

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention - Cuff Leak TestDexamethasone 4mgA respiratory therapist will perform a Cuff Leak Test on all patients prior to extubation. If no air leak is auscultated (a failed CLT), extubation will be delayed. During this time, the patient will receive dexamethasone 4mg intravenous every 6 hours for 12-24 hours and the clinical team will be advised to consider optimizing a patient's fluid status through either diuresis or ultrafiltration if the patient has renal failure. After 12-24 hours, and once the clinical team decides the patient is ready for another extubation attempt, the CLT will be repeated. If the patient fails the CLT again, it will be at the discretion of the clinical team how to proceed (i.e. continue steroid administration, and further delay extubation vs immediately extubating despite a failed CLT) (Figure 3). A passed CLT at any time point will result in immediate extubation.
Intervention - Cuff Leak TestCuff Leak TestA respiratory therapist will perform a Cuff Leak Test on all patients prior to extubation. If no air leak is auscultated (a failed CLT), extubation will be delayed. During this time, the patient will receive dexamethasone 4mg intravenous every 6 hours for 12-24 hours and the clinical team will be advised to consider optimizing a patient's fluid status through either diuresis or ultrafiltration if the patient has renal failure. After 12-24 hours, and once the clinical team decides the patient is ready for another extubation attempt, the CLT will be repeated. If the patient fails the CLT again, it will be at the discretion of the clinical team how to proceed (i.e. continue steroid administration, and further delay extubation vs immediately extubating despite a failed CLT) (Figure 3). A passed CLT at any time point will result in immediate extubation.
Primary Outcome Measures
NameTimeMethod
Recruitment Rate1 Year

Define a successful recruitment rate as enrolling three patients per centre per month over the duration of the trial. While the pilot trial is ongoing, steering committee will review recruitment weekly and the screening records monthly. If applicable, we will address barriers to enrolment to maximise recruitment. The recruitment metric will be measured and interpreted at the end of the pilot trial by calculating the mean number of recruited patients per active screening month.

Protocol Adherence30 days

Define a successful adherence rate as ≥75%. We will calculate the adherence as the proportion of patients that are assigned to the intervention arm following the appropriate treatment algorithm and those assigned to the control arm being extubated without a cuff leak test. As this pilot trial is ongoing, we will review adherence monthly and investigate the reasons for compliance failure. We will investigate all reasons for failure to follow the treatment algorithm in the intervention arm, failure to extubate after a patient passes a CLT in the intervention arm, or failure to extubate immediately after randomization in the control arm and report them as a protocol violation. The RC will review the RT's charting and the medication profile to determine actual compliance. RC will record all reasons for non-compliance using distinguishing clinical reasons (eg, palliation, death, consent withdrawal and errors).

Secondary Outcome Measures
NameTimeMethod
Hospital MortalityWithin 30 days of Randomization

Death during Intensive Care Unit admission

Proportion of patients with Clinically Significant post-extubation stridorwithin 72 hours of extubation;

Defined as the presence of an inspiratory noise following extubation that requires medical intervention such as racemic epinephrine

Proportion of patients with Emergency Surgical Airwaywithin 72 hours of extubation

A procedure performed to secure the airway in patients with upper airway obstruction who could not be managed with intubation or mechanical ventilation.

Proportion of patients with Ventilator Associated Pneumonia30 Days from Randomization

Pneumonia occurring more than 48 h after patients have been intubated and received mechanical ventilation.

ICU MortalityWithin 30 days of Randomization

Death during Intensive Care Unit admission

Proportion of patients Reintubationwithin 72 hours of extubation;

Re insertion of an endotracheal tube to maintain an airway within 72 hours for any reason (reasons for reintubation will be captured)

Proportion of patients with Post-extubation stridorwithin 72 hours of extubation

Defined as the presence of an inspiratory noise following extubation.

Ventilator Free DaysWithin 30 Days of Randomization

Number of days alive and free of mechanical ventilation.

Length of StayWithin 30 days of Randomization

Number of days admitted to hospital

ICU Length of StayWithin 30 days of Randomization

Number of days admitted to the ICU

Trial Locations

Locations (5)

Al-Amiri Hospital

🇰🇼

Kuwait City, Kuwait

The University of Texas Health Science Center at Houston

🇺🇸

Houston, Texas, United States

Brantford General Hospital

🇨🇦

Brantford, Ontario, Canada

St. Joseph's Healthcare Hamilton

🇨🇦

Hamilton, Ontario, Canada

Niagara Health System

🇨🇦

St. Catherines, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath